Published in Proc Natl Acad Sci U S A on October 01, 1986
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A (1992) 4.94
Oral tolerance. Immunol Rev (2005) 3.48
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A (1991) 3.19
Oral tolerance. Immunol Rev (2011) 3.03
Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci U S A (1992) 2.73
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A (1991) 2.72
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68
Antigen-driven bystander suppression after oral administration of antigens. J Exp Med (1991) 2.62
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest (1996) 2.27
Oral tolerance to food protein. Mucosal Immunol (2012) 1.90
Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci U S A (1994) 1.66
A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci U S A (1997) 1.40
Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med (1989) 1.39
Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci U S A (1996) 1.38
Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol (1996) 1.27
Psoriasis, T cells and autoimmunity. J R Soc Med (1996) 1.19
Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model. Arthritis Res Ther (2008) 1.19
Oral tolerance in disease. Gut (1999) 1.17
Oral tolerance. J Clin Immunol (1998) 1.11
Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci U S A (1992) 1.10
Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology (1993) 1.05
Tolerogenic activity of polymerized type II collagen in preventing collagen-induced arthritis in rats. Clin Exp Immunol (1988) 0.97
Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A (1997) 0.96
Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology (1997) 0.95
Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis. Clin Exp Immunol (2003) 0.91
Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis. Inflamm Res (2009) 0.90
Low dose native type II collagen prevents pain in a rat osteoarthritis model. BMC Musculoskelet Disord (2013) 0.88
Identification and characterization of a major tolerogenic T-cell epitope of type II collagen that suppresses arthritis in B10.RIII mice. Immunology (1995) 0.88
Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis. Mol Ther (2009) 0.86
Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice. Immunology (1998) 0.86
Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice. Clin Exp Immunol (2002) 0.86
A review of the mechanisms of oral tolerance and immunotherapy. J R Soc Med (1995) 0.84
Acquired resistance to type II collagen-induced arthritis in rhesus monkeys is reflected by a T cell low-responsiveness to the antigen. Clin Exp Immunol (1991) 0.83
Oral desensitisation in rheumatoid arthritis. Ann Rheum Dis (1994) 0.82
Type II collagen serology: a guide to clinical responsiveness to oral tolerance? Rheumatol Int (1997) 0.81
Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans? Rev Diabet Stud (2004) 0.81
Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. J Int Soc Sports Nutr (2013) 0.81
Contribution of the spleen, lymph nodes and bone marrow to the antibody response in collagen-induced arthritis in the rat. Clin Exp Immunol (1991) 0.80
Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells. Immunology (1999) 0.79
Therapeutic advances in immunosuppression. Clin Exp Immunol (1994) 0.79
Induction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease. ORL J Otorhinolaryngol Relat Spec (2009) 0.78
Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case. Microb Cell Fact (2014) 0.77
Treating arthritis by immunomodulation: is there a role for regulatory T cells? Rheumatology (Oxford) (2010) 0.77
The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion. Clin Immunol (2015) 0.77
Clinical potential of antigen-specific therapies in type 1 diabetes. Rev Diabet Stud (2012) 0.76
Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis. PLoS One (2016) 0.76
Metabolic syndrome - Removing roadblocks to therapy: Antigenic immunotherapies. Mol Metab (2014) 0.76
Changes in microarchitectural characteristics at the tibial epiphysis induced by collagen-induced rheumatoid arthritis over time. Clin Interv Aging (2012) 0.75
Nutritional Approach for Relief of Joint Discomfort: A 12-week, Open-case Series and Illustrative Case Report. Integr Med (Encinitas) (2015) 0.75
Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritis. Arthritis Res Ther (2016) 0.75
Orally tolerant CD4 T cells respond poorly to antigenic stimulation but strongly to direct stimulation of intracellular signaling pathways. Cytotechnology (2001) 0.75
Low-affinity antibodies against collagen type II produced by lymph node cells are associated with pathology in collagen-induced arthritis in rats. Clin Exp Immunol (1992) 0.75
Antigen-based immunotherapy for autoimmune disease: current status. Immunotargets Ther (2014) 0.75
Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis. PLoS One (2017) 0.75
Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol (1972) 40.51
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Immunisation against heterologous type II collagen induces arthritis in mice. Nature (1980) 7.08
Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76
Assessing B cell diversification by antigen receptor and precursor cell analysis. Ann Immunol (Paris) (1976) 3.88
Systemic tolerance and secretory immunity after oral immunization. J Exp Med (1980) 3.79
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
ELECTROPHORETIC SEPARATION AND PROPERTIES OF MOUSE ANTIHAPTEN ANTIBODIES INVOLVED IN PASSIVE CUTANEOUS ANAPHYLAXIS AND PASSIVE HEMOLYSIS. J Exp Med (1964) 3.58
Preparation and characterization of the different types of collagen. Methods Enzymol (1982) 3.12
Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy Appl Immunol (1969) 2.92
Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J Immunol (1978) 2.86
Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J Immunol (1978) 2.69
The induction of tolerance to a soluble protein antigen by oral administration. Immunology (1974) 2.50
Absorption of antigens after oral immunisation and the simultaneous induction of specific systemic tolerance. Gut (1979) 2.40
Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29
Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin. J Immunol (1979) 2.29
Enterically induced immunologic tolerance. I. Induction of suppressor T lymphoyctes by intragastric administration of soluble proteins. J Immunol (1978) 2.17
Oral tolerance. Transplantation (1980) 2.17
Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding. J Immunol (1981) 2.03
Specificity of the antibody response in inbred mice to bovine type I and type II collagen. Immunology (1975) 1.77
H-2-linked genetic control of antibody response to soluble calf skin collagen in mice. Eur J Immunol (1975) 1.56
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52
Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum (1984) 1.52
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Orally induced tolerance. Definition at the cellular level. Int Arch Allergy Appl Immunol (1981) 1.48
Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48
Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin. Arthritis Rheum (1983) 1.42
Cellular, molecular, and genetic characteristics of T cell reactivity to collagen in man. Proc Natl Acad Sci U S A (1981) 1.41
Antigen-specific suppression of type II collagen-induced arthritis by collagen-coupled spleen cells. J Immunol (1982) 1.25
Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cells. Clin Immunol Immunopathol (1984) 1.10
Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity. J Immunol (1985) 1.06
Adoptive transfer of suppression of arthritis in the mouse model of collagen-induced arthritis. Evidence for a type II collagen-specific suppressor T cell. J Clin Invest (1985) 1.00
Abrogation by subsequent feeding of antibody response including IgE, in parenterally immunized mice. J Exp Med (1982) 0.99
Collagen-induced and adjuvant-induced arthritis in rats. Post-immunization treatment with collagen to suppress or abrogate the arthritic response. Arthritis Rheum (1984) 0.95
Oral-parenteral immunization leads to the appearance of IgG auto-anti-idiotypic cells in mucosal tissues. Cell Immunol (1981) 0.84
Production of auto-anti-idiotypic antibody during the normal immune response. XII. Enhanced auto-anti-idiotypic antibody production as a mechanism for apparent B-cell tolerance in rabbits after feeding antigen. Cell Immunol (1986) 0.83
Type II collagen-reactive T cell clones from mice with collagen-induced arthritis. J Immunol (1985) 0.81
The specific refraction increments of serum-albumin and serum-globulin. Biochem J (1930) 38.06
The analysis of the osmotic pressures of the serum proteins, and the molecular weights of albumins and globulins. Biochem J (1930) 17.84
Oxidising Enzymes: The Oxidation of Certain Parahydroxy-compounds by Plant Enzymes and its Connection with "Tyrosinase". Biochem J (1925) 9.84
Cell selection by antigen in the immune response. Adv Immunol (1969) 6.05
Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol (1976) 4.52
Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med (2000) 4.09
The Nitroprusside Reaction of Bacteria. Biochem J (1925) 3.36
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A (1991) 3.19
Secondary antibody responses in haptenic systems: cell population selection by antigen. J Immunol (1967) 3.01
Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain (1998) 2.99
The liver as the site of C-reactive protein formation. J Exp Med (1966) 2.76
Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain (1997) 2.41
Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am J Pathol (1983) 2.38
Dendritic cells in the immune response: characteristics and recommended nomenclature (A report from the Reticuloendothelial Society Committee on Nomenclature). J Reticuloendothel Soc (1982) 2.34
Relationship of germinal centers in lymphoid tissue to immunologic memory. VI. Transfer of B cell memory with lymph node cells fractionated according to their receptors for peanut agglutinin. J Immunol (1983) 2.29
Distribution of antibody affinities: technique of measurement. Immunochemistry (1972) 2.24
A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol (1990) 2.24
Studies on the induction of immunological unresponsiveness to pneumococcal polysaccharide in mice. J Exp Med (1966) 2.24
A meta-analytic review of pain perception across the menstrual cycle. Pain (1999) 2.22
Studies on the control of antibody synthesis. Effect of antibody affinity upon its ability to suppress antibody formation. Immunology (1968) 2.20
Oxidising Enzymes: On the Mechanism of Plant Oxidases. Biochem J (1926) 2.18
Studies on the effect of the carrier molecule on antihapten antibody synthesis. I. Effect of carrier on the nature of the antibody synthesized. J Exp Med (1966) 2.16
Langerhans cells as macrophages in skin and lymphoid organs. J Invest Dermatol (1980) 2.16
Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) mice. Cell Immunol (1974) 2.15
Langerhans cells: role in contact hypersensitivity and relationship to lymphoid dendritic cells and to macrophages. Immunol Rev (1980) 2.10
Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07
Sites of synthesis of serum proteins. OI. Serum proteins produced by macrophages in vitro. J Immunol (1967) 1.96
Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies. J Exp Med (1966) 1.94
Oxidising enzymes: The relationship of oxygenase to tyrosinase. Biochem J (1928) 1.92
Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med (1996) 1.91
Studies on the control of antibody synthesis. Interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response. J Exp Med (1967) 1.89
Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized. J Exp Med (1968) 1.89
Sites of production of primate serum proteins associated with complement system. Proc Soc Exp Biol Med (1967) 1.88
Catastrophizing, depression and the sensory, affective and evaluative aspects of chronic pain. Pain (1994) 1.88
Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts. J Exp Med (1969) 1.86
Ontogeny of B-lymphocyte function. I. Restricted heterogeneity of the antibody response of B lymphocytes from neonatal and fetal mice. J Exp Med (1974) 1.86
SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): I. A NEW TECHNIQUE FOR THE DEMONSTRATION OF THE SYNTHESIS OF INDIVIDUAL SERUM PROTEINS BY TISSUES IN VITRO. J Exp Med (1961) 1.83
Selection of cell populations in induction of tolerance: affinity of antibody formed in partially tolerant rabbits. J Immunol (1968) 1.82
A study of the 'termination' of tolerance to BSA with DNP-BSA in rabbits: relative affinities of the antibodies for the immunizing and the paralysing antigens. Immunology (1967) 1.82
Comparative prevalence rates of sexually transmitted diseases in heterosexual and homosexual men. Am J Epidemiol (1980) 1.81
Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain (2001) 1.71
Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest (1997) 1.69
Surface antigens of immunocompetent cells. I. Effect of theta and PC.1 alloantisera on the ability of spleen cells to transfer immune responses. J Exp Med (1970) 1.65
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody. J Immunol (1968) 1.61
Reduced Langerhans' cell Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. N Engl J Med (1984) 1.60
Beta-1C and immune globulin formation in vitro by tissues from germ-free and conventional rodents of various ages. Immunology (1967) 1.52
Immunoglobulins, antibodies and the bursa of Fabricus: induction of agammaglobulinemia and the loss of all antibody-forming capacity by hormonal bursectomy. J Immunol (1969) 1.52
Contact hypersensitivity and Langerhans cells. J Invest Dermatol (1980) 1.51
Staining of Langerhans cells with monoclonal antibodies to macrophages and lymphoid cells. Proc Natl Acad Sci U S A (1983) 1.50
Sites of synthesis of serum proteins. 3. Production of beta-1-C, beta-1-E and transferrin by primate and rodent cell lines. J Immunol (1967) 1.46
CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest (2000) 1.43
Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1972) 1.39
Langerhans cells: a review of their nature with emphasis on their immunologic functions. Prog Allergy (1978) 1.37
Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas. J Exp Med (1984) 1.37
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood (1969) 1.35
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci U S A (2000) 1.33
Studies on the serum proteins of chimeras. I. Identification and study of the site of origin of donor type serum proteins in adult rat-into-mouse chimeras. Int Arch Allergy Appl Immunol (1966) 1.31
Dermal and intravascular Langerhans cells at sites of passively induced allergic contact sensitivity. Cell Immunol (1975) 1.30
CD30 in normal and neoplastic cells. Clin Immunol (1999) 1.29
Tolerance in adult rabbits by repeated non-immunogenic doses of bovine serum albumin. Immunology (1967) 1.27
Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J Immunol (1993) 1.27
Studies on antigenic competition. J Exp Med (1969) 1.26
Overall fibromyalgia pain is predicted by ratings of local pain and pain-related negative affect--possible role of peripheral tissues. Rheumatology (Oxford) (2006) 1.26
Effect of tolerance and immunity on antibody affinity. Transplant Rev (1972) 1.25
Immune globulin production by the bursa of Fabricius of young chickens. Immunology (1968) 1.24
Formation of C'-6 by rabbit liver tissue in vitro. Immunology (1968) 1.24
Transfer of antibody production with cells from bursa of Fabricius. J Exp Med (1970) 1.23
The effect of dose in tolerance induction on the subsequent response to a cross-reactive antigen. Immunology (1969) 1.23
Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein. Arthritis Rheum (2000) 1.23
Studies on the control of antibody synthesis. VI. Effect of antigen dose and time after immunization on antibody affinity and heterogeneity in the mouse. Clin Exp Immunol (1974) 1.22
Studies on immunological paralysis. I. A consideration of macrophage involvement in the induction of paralysis and immunity by type II pneumococcal polysaccharide. Clin Exp Immunol (1969) 1.22
Among naive precursor cell subpopulations only progenitors of memory B cells originate germinal centers. Eur J Immunol (1992) 1.19
Ontogeny of B-lymphocyte function. II. Ability of endotoxin to increase the heterogeneity of affinity of the immune response of B lymphocytes from fetal mice. J Exp Med (1976) 1.18
Autologous and allogeneic stimulation of peripheral human leukocytes. Cell Immunol (1972) 1.18
Relationship of germinal centers in lymphoid tissue to immunologic memory. V. The effect of prednisolone administered after the peak of the primary response. J Immunol (1971) 1.17
SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): II. PRODUCTION OF IMMUNOELECTROPHORETICALLY IDENTIFIED SERUM PROTEINS BY HUMAN AND MONKEY TISSUES IN VITRO. J Exp Med (1961) 1.17
Relationship of germinal centers in lymphoid tissue to immunological memory. I. Evidence for the formation of small lymphocytes upon transfer of primed splenic white pulp to syngeneic mice. J Exp Med (1968) 1.15
The path of memory B-cell development. Immunol Rev (1992) 1.14
Sex, gender, and blood pressure: contributions to experimental pain report. Psychosom Med (2001) 1.12
Serum protein formation of donor type in rat-into-mouse chimaeras. Nature (1965) 1.11
Negative affect, self-report of depressive symptoms, and clinical depression: relation to the experience of chronic pain. Clin J Pain (2000) 1.10
Studies on the control of antibody synthesis. XII. Genetic influences on antibody affinity. Immunology (1978) 1.10
The role of circulating antibody in the control of antibody synthesis: mechanism for the suppressive effect of passive antibody on active antibody synthesis. Transfusion (1968) 1.10
The importance of theta and Ig hearing cells in the immune response to various antigens. J Immunol (1971) 1.10
CSQ: five factors or fiction? Clin J Pain (1997) 1.10
CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. J Immunol (1999) 1.09
Production of auto-anti-idiotypic antibody during the normal immune response: changes in the auto-anti-idiotypic antibody response and the idiotype repertoire associated with aging. Proc Natl Acad Sci U S A (1980) 1.09
Relationship of germinal centers in lymphoid tissue to immunological memory. II. The detection of primed cells and their proliferation upon cell transfer to lethally irradiated syngeneic mice. J Exp Med (1968) 1.08
The physiology of germinal centers. Crit Rev Immunol (1996) 1.08
Immunocompetent cells of the chicken. I. Specific surface antigenic markers on bursa and thymus cells. J Exp Med (1971) 1.08
Gamma-globulin and antibody formation in vitro. V. The secondary response made by splenic white and red pulp with reference to the role of secondary nodules. J Immunol (1966) 1.07
Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J (1993) 1.07
Relationship of germinal centers in lymphoid tissue to immunologic memory. IV. Formation of 19S and 7S antibody by splenic white and red pulp during the secondary response in vitro. Lab Invest (1968) 1.07